Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/30/17
End: 04/29/17
Due: 04/29/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections | NCT03038971 | Woodmont Pharmaceuticals, Inc. | user2@example.com | None | 2017-03-30 | 2017-04-29 | 2018-04-29 | - | - | 2025-07-14 |